[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"bladder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:bladder":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100642974","filling-protocols-for-the-right-bladder-volume-at-the-right-time-fillright-100642974",false,"NCT07642570","FILLing Protocols for the Right Bladder Volume at the RIGHT Time (FILLRIGHT)","FILLing Protocols for the Right Bladder Volume at the RIGHT Time","FILLRIGHT","Inclusion Criteria:\n\n* Adult woman\n* Nulliparous woman\n* Affiliated with a social security system\n\nExclusion Criteria:\n\n* Pregnant woman\n* Menopause\n* History of hysterectomy\n* Absence of uterus\n* Symptoms of urinary tract infection (macroscopic hematuria, burning during urination, pollakiuria)\n* Overactive bladder defined by the clinical question: \"Do you have an urgent need to urinate, difficult to control, sometimes resulting in leakage?\"\n* Under legal protection (guardianship, conservatorship)\n* Refusal to participate",true,"FEMALE","18 Years",{"count":21,"type":22},20,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to compare evaluation of oral hydration protocols for the right optimal bladder filling prior to pelvic ultrasound.\n\nThe main question it aims to answer is which quantity of water should patiente drink before a pelvic ultrasound.\n\nWoman participants will drink 4 differents quantity of water over 4 differents days:\n\n* Quantity A : 1000 ml in 15 minutes\n* Quantity B : 750 ml in 10 minutes\n* Quantity C : 500 ml in 5 minutes\n* Quantity D : 250 ml in 1 minutes\n\nThe order of the hydration protocols will be randomized.\n\nAll procedures are performed in the same way:\n\n* Before ingestion of water, the patient should urinate band (the volumen will be measured) an an ultrasound examination will be performed to assess the residual post-void volume\n* The patiente drinks water and the time was collected\n* Every 5 minutes during the procedure :\n\n  * A suprapubic ultrasound examination will be performed to assess the bladder filling and to calculate of bladder volume using the standard formula (length × width × height × 0.52)\n  * The Bladder Sensation Scale (BSS) was collected.\n* When the score to BBS reaches 3, the procedure should be stopped and the patiente should urinate band (the volumen will be measured). Then a last ultrasound examination will be performed.\n\nAfter each procedure, the patiente answer at this question: \"On a scale from 1 (very poor) to 10 (excellent), how would you rate the acceptability of ingesting the required hydration volume?\"",[28],"Bladder","NOT_YET_RECRUITING","2026-06-08",{"date":32,"type":33},"2026-06-11","ACTUAL",{"date":35,"type":22},"2026-09-01",{"date":37,"type":22},"2028-08-01",{"name":39,"class":40},"University Hospital, Brest","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":18,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":23,"phases":53,"briefSummary":54,"conditions":55,"keywords":60,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":41},"100636290","low-energy-shock-wave-therapy-for-overactive-bladder-in-women-with-metabolic-syndrome-100636290","NCT07563764","Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic Syndrome","A Randomized, Double-Blind, Sham-Controlled Trial of Low-Energy Extracorporeal Shock Wave Therapy for Overactive Bladder in Women With Metabolic Syndrome","Inclusion:\n\n* Female participants aged 20 to 75 years\n* Diagnosed with overactive bladder (OAB), defined as urinary frequency (≥8 times\u002Fday), nocturia (≥2 times\u002Fnight), and urgency (≥2 episodes\u002Fweek) for at least 3 months\n* Diagnosed with metabolic syndrome, defined by the presence of at least three of the following criteria:\n* Waist circumference ≥80 cm\n* Blood pressure ≥130\u002F85 mmHg or receiving antihypertensive treatment\n* Fasting glucose ≥100 mg\u002FdL or receiving treatment for diabetes\n* Triglycerides ≥150 mg\u002FdL or receiving lipid-lowering treatment\n* High-density lipoprotein cholesterol \\\u003C50 mg\u002FdL\n* No pharmacological or injection treatment for OAB within 3 months prior to enrollment\n* Able to understand and comply with study procedures and questionnaires\n* Willing to provide informed consent\n\nExclusion:\n\n* History of kidney stones or bladder stones\n* Urinary tract infection within 3 months prior to enrollment or recurrent urinary tract infections (≥3 episodes)\n* Lower urinary tract surgery within 6 months prior to enrollment\n* Known or suspected malignancy of the urinary tract\n* Significant bladder outlet obstruction\n* Severe coagulopathy, liver failure, or renal failure\n* Prior pelvic malignancy or pelvic radiation therapy\n* Intravesical injection or electrical stimulation therapy within the past year\n* Substance abuse (drug or alcohol) within the past year\n* Chronic pelvic pain due to other causes\n* Inability to complete study questionnaires or procedures","20 Years","75 Years",{"count":52,"type":22},60,[25],"Overactive bladder (OAB) is a common condition that causes urinary urgency, frequent urination, and nocturia, which can significantly affect quality of life. Women with metabolic syndrome may have a higher risk of OAB due to vascular and metabolic abnormalities.\n\nThis study aims to evaluate the effectiveness and safety of low-energy extracorporeal shock wave therapy (LiESWT), a non-invasive treatment, in women with metabolic syndrome-associated OAB. Participants will be randomly assigned to receive either active LiESWT treatment or a sham (inactive) procedure.\n\nSymptoms and treatment outcomes will be assessed using validated questionnaires, including the Overactive Bladder Symptom Score (OABSS), International Consultation on Incontinence Questionnaire (ICIQ-SF), Urinary Distress Inventory (UDI-6), and Incontinence Impact Questionnaire (IIQ-7), as well as a voiding diary and uroflow measurements.\n\nThe results of this study may help determine whether LiESWT is an effective treatment option for improving OAB symptoms in this patient population.",[28,56,57,58,59],"Lower Urinary Track Symptoms","Metabolic Syndrome","Urgency-Frequency","Bladder, Overactive",[61,62,63,64,65,66,67,68],"Low-energy extracorporeal shock wave therapy","LiESWT","Overactive bladder","Metabolic syndrome","Urinary urgency","Urinary frequency","Nocturia","Randomized controlled trial","RECRUITING","2026-04-30",{"date":72,"type":33},"2026-05-04",{"date":74,"type":33},"2025-02-10",{"date":76,"type":22},"2026-06-30",{"name":78,"class":40},"KMUHIRB-F(I)-20230051"]